Jolanda Howe - Nov 14, 2024 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
SVP, GLOBAL CONTROLLER
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Nov 14, 2024
Transactions value $
-$110,402
Form type
4
Date filed
11/15/2024, 05:34 PM
Previous filing
Jul 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Options Exercise $7.35K +2.5K +103.05% $2.94 4.93K Nov 14, 2024 Direct
transaction MIRM Common Stock Sale -$118K -2.5K -50.75% $47.10 2.43K Nov 14, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRM Stock Option (right to buy) Options Exercise $0 -2.5K -4.51% $0.00 52.9K Nov 14, 2024 Common Stock 2.5K $2.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the 62,500 shares originally subject to the option vested one year after February 28, 2019, and the balance of the shares vest in a series of 36 successive equal monthly installments at the end of each month thereafter.